These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 24678775)

  • 1. The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targets.
    Shao WH; Cohen PL
    Expert Rev Clin Immunol; 2014 May; 10(5):573-82. PubMed ID: 24678775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of BTK prevents murine lupus and antibody-mediated glomerulonephritis.
    Rankin AL; Seth N; Keegan S; Andreyeva T; Cook TA; Edmonds J; Mathialagan N; Benson MJ; Syed J; Zhan Y; Benoit SE; Miyashiro JS; Wood N; Mohan S; Peeva E; Ramaiah SK; Messing D; Homer BL; Dunussi-Joannopoulos K; Nickerson-Nutter CL; Schnute ME; Douhan J
    J Immunol; 2013 Nov; 191(9):4540-50. PubMed ID: 24068666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spleen tyrosine kinase: an Src family of non-receptor kinase has multiple functions and represents a valuable therapeutic target in the treatment of autoimmune and inflammatory diseases.
    Ghosh D; Tsokos GC
    Autoimmunity; 2010 Feb; 43(1):48-55. PubMed ID: 20001666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell receptor-associated protein tyrosine kinases: the dynamics of tolerance regulation by phosphorylation and its role in systemic lupus erythematosus.
    Barrera-Vargas A; Gómez-Martín D; Alcocer-Varela J
    Hum Immunol; 2014 Sep; 75(9):945-52. PubMed ID: 25173412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell receptor signaling in human systemic lupus erythematosus.
    Pugh-Bernard AE; Cambier JC
    Curr Opin Rheumatol; 2006 Sep; 18(5):451-5. PubMed ID: 16896281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting lymphocyte signaling pathways as a therapeutic approach to systemic lupus erythematosus.
    Kyttaris VC; Tsokos GC
    Curr Opin Rheumatol; 2011 Sep; 23(5):449-53. PubMed ID: 21720246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus.
    Iwata S; Yamaoka K; Niiro H; Jabbarzadeh-Tabrizi S; Wang SP; Kondo M; Yoshikawa M; Akashi K; Tanaka Y
    Lupus; 2015 Jun; 24(7):695-704. PubMed ID: 25432781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell and B-cell signaling biomarkers and treatment targets in lupus.
    Perl A; Fernandez DR; Telarico T; Doherty E; Francis L; Phillips PE
    Curr Opin Rheumatol; 2009 Sep; 21(5):454-64. PubMed ID: 19550330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the B Cell-Centric View of Systemic Lupus Erythematosus.
    Morawski PA; Bolland S
    Trends Immunol; 2017 May; 38(5):373-382. PubMed ID: 28274696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cells biology in systemic lupus erythematosus-from bench to bedside.
    Zhao L; Ye Y; Zhang X
    Sci China Life Sci; 2015 Nov; 58(11):1111-25. PubMed ID: 26563177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatments.
    Liossis SN; Melissaropoulos K
    Expert Opin Pharmacother; 2014 Apr; 15(6):833-40. PubMed ID: 24588739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune cell biochemical abnormalities in systemic lupus erythematosus.
    Liossis SN; Vassilopoulos D; Kovacs B; Tsokos GC
    Clin Exp Rheumatol; 1997; 15(6):677-84. PubMed ID: 9444427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of systemic lupus erythematosus.
    Francis L; Perl A
    Expert Opin Pharmacother; 2009 Jun; 10(9):1481-94. PubMed ID: 19505215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating proximal cell signaling by targeting Btk ameliorates humoral autoimmunity and end-organ disease in murine lupus.
    Hutcheson J; Vanarsa K; Bashmakov A; Grewal S; Sajitharan D; Chang BY; Buggy JJ; Zhou XJ; Du Y; Satterthwaite AB; Mohan C
    Arthritis Res Ther; 2012 Nov; 14(6):R243. PubMed ID: 23136880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapeutic approaches in systemic lupus erythematosus.
    Kiss E; Szodoray P
    Front Biosci (Schol Ed); 2010 Jan; 2(1):221-8. PubMed ID: 20036942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From T to B and back again: positive feedback in systemic autoimmune disease.
    Shlomchik MJ; Craft JE; Mamula MJ
    Nat Rev Immunol; 2001 Nov; 1(2):147-53. PubMed ID: 11905822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of B cell receptor-associated signaling molecules in human lupus.
    Huck S; Le Corre R; Youinou P; Zouali M
    Autoimmunity; 2001 May; 33(3):213-24. PubMed ID: 11683380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dualistic role of Lyn tyrosine kinase in immune cell signaling: implications for systemic lupus erythematosus.
    L'Estrange-Stranieri E; Gottschalk TA; Wright MD; Hibbs ML
    Front Immunol; 2024; 15():1395427. PubMed ID: 39007135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular targeting in autoimmunity.
    Rogers JL; Serafin DS; Timoshchenko RG; Tarrant TK
    Curr Allergy Asthma Rep; 2012 Dec; 12(6):495-510. PubMed ID: 23054625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune cells and cytokines in systemic lupus erythematosus: an update.
    Kyttaris VC; Juang YT; Tsokos GC
    Curr Opin Rheumatol; 2005 Sep; 17(5):518-22. PubMed ID: 16093827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.